Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study
This 2012 randomized controlled trial published in the Journal of the Medical Association of Thailand (PMID: 23193746) evaluated the efficacy and safety of 3% minoxidil (MNX) versus a combination of 3% minoxidil and 0.1% finasteride (MFX) in 40 men with androgenetic alopecia (AGA) over 24 weeks. The MFX group showed
June 26, 2025
No Comments